No abstract

Influenza vaccine composition is reviewed before every flu season because influenza viruses constantly evolve through antigenic changes. To inform vaccine updates, laboratories that contribute to the World Health Organization Global Influenza Surveillance and Response System monitor the antigenic phenotypes of circulating viruses all year round. Vaccine strains are selected in anticipation of the upcoming influenza season to allow adequate time for production. A mismatch between vaccine strains and predominant strains in the flu season can significantly reduce vaccine effectiveness. Models for predicting the evolution of influenza based on the relationship of genetic mutations and antigenic characteristics of circulating viruses may inform vaccine strain selection decisions. We review the literature on state-of-the-art tools and prediction methodologies utilized in modeling the evolution of influenza to inform vaccine strain selection. We then discuss areas that are open for improvement and need further research.

No abstract

No abstract

No abstract